Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Dominguez
Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly
British Journal of Cancer
Cancer Research
Oncology
Related publications
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Adjuvant Oxaliplatin- Or Irinotecan-Containing Chemotherapy Improves Overall Survival Following Resection of Metachronous Colorectal Liver Metastases
International Journal of Colorectal Disease
Gastroenterology
Irinotecan-Based Combination Chemotherapy for Metastatic Small Intestinal Adenocarcinoma
Oncology Letters
Cancer Research
Oncology
Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report
The Open Colorectal Cancer Journal
Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal Carcinoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies
Cancer Research and Treatment
Cancer Research
Oncology
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Clinical Significance of UGT1A1 Gene Polymorphisms on Irinotecan-Based Regimens as the Treatment in Metastatic Colorectal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
